ATE105856T1 - Serumfreie wachstumsmedien für insektenzellen und expression von produkten damit. - Google Patents

Serumfreie wachstumsmedien für insektenzellen und expression von produkten damit.

Info

Publication number
ATE105856T1
ATE105856T1 AT88906600T AT88906600T ATE105856T1 AT E105856 T1 ATE105856 T1 AT E105856T1 AT 88906600 T AT88906600 T AT 88906600T AT 88906600 T AT88906600 T AT 88906600T AT E105856 T1 ATE105856 T1 AT E105856T1
Authority
AT
Austria
Prior art keywords
serum
products
insect cells
expression
growth media
Prior art date
Application number
AT88906600T
Other languages
English (en)
Inventor
Duane Inlow
Brian Maiorella
Original Assignee
Cetus Oncology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Oncology Corp filed Critical Cetus Oncology Corp
Application granted granted Critical
Publication of ATE105856T1 publication Critical patent/ATE105856T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0601Invertebrate cells or tissues, e.g. insect cells; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/36Lipids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/50Soluble polymers, e.g. polyethyleneglycol [PEG]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/70Undefined extracts
    • C12N2500/74Undefined extracts from fungi, e.g. yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/70Undefined extracts
    • C12N2500/80Undefined extracts from animals
    • C12N2500/84Undefined extracts from animals from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/90Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14111Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT88906600T 1987-07-24 1988-07-20 Serumfreie wachstumsmedien für insektenzellen und expression von produkten damit. ATE105856T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/077,303 US5024947A (en) 1987-07-24 1987-07-24 Serum free media for the growth on insect cells and expression of products thereby

Publications (1)

Publication Number Publication Date
ATE105856T1 true ATE105856T1 (de) 1994-06-15

Family

ID=22137290

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88906600T ATE105856T1 (de) 1987-07-24 1988-07-20 Serumfreie wachstumsmedien für insektenzellen und expression von produkten damit.

Country Status (10)

Country Link
US (1) US5024947A (de)
EP (1) EP0380495B1 (de)
JP (1) JP2898291B2 (de)
AT (1) ATE105856T1 (de)
AU (1) AU2126688A (de)
CA (1) CA1309679C (de)
DE (1) DE3889665T2 (de)
IE (1) IE64262B1 (de)
IL (1) IL87196A (de)
WO (1) WO1989001028A1 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763573A (en) * 1988-08-10 1998-06-09 Chiron Corporation GTPase activating protein fragments
US5760203A (en) * 1988-08-10 1998-06-02 Chiron Corporation Gap gene sequences
US5272063A (en) * 1988-11-22 1993-12-21 Syntex (U.S.A.) Inc. Process of making human nerve growth factor
ES2112866T3 (es) * 1990-09-25 1998-04-16 Smithkline Beecham Corp Medios para el cultivo de celulas de drosophila.
CA2091443A1 (en) * 1990-09-25 1992-03-26 Luciano Ramos Medium for culture of mammalian cells
JPH04228066A (ja) * 1990-10-23 1992-08-18 Rikagaku Kenkyusho 外来遺伝子発現用培養細胞
JPH0671432B2 (ja) * 1991-03-20 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
US5318898A (en) * 1991-04-02 1994-06-07 Genetics Institute, Inc. Production of recombinant bone-inducing proteins
KR100270195B1 (ko) * 1991-09-06 2001-03-02 와일러 제임스 에프. 겔로닌 폴리펩타이드를 암호화하는 dna 서열
US5298418A (en) * 1991-09-16 1994-03-29 Boyce Thompson Institute For Plant Research, Inc. Cell line isolated from larval midgut tissue of Trichoplusia ni
US5405770A (en) * 1993-01-21 1995-04-11 The United States Of America As Represented By The Secretary Of Agriculture Heliothis subflexa cell line for the production of baculoviruses
US5348877A (en) * 1993-03-12 1994-09-20 Boyce Thompson Institute For Plant Research, Inc. Method of adapting anchorage-dependent cell lines to suspension conditions
WO1994026087A2 (en) * 1993-05-14 1994-11-24 Connor Kim C O Recombinant protein production and insect cell culture and process
US5550019A (en) 1993-05-26 1996-08-27 La Jolla Cancer Research Foundation Methods of identifying compounds which alter apoptosis
US5426045A (en) * 1993-12-16 1995-06-20 Sea Run Holdings, Inc. Method for culturing mammalian cells in a medium containing fish serum
US5641678A (en) * 1994-01-18 1997-06-24 Smithkline Beecham Corporation Serum-free culture medium for drosphila insect cells
US5498540A (en) * 1994-02-23 1996-03-12 Sea Run Holdings, Inc. Method for culturing insect cells in a medium containing fish serum
US6403375B1 (en) * 1994-08-24 2002-06-11 Boyce Thompson Institute For Plant Research, Inc. Establishment of Trichoplusia ni cell lines in serum-free medium for recombinant protein and baculovirus production
FR2726574B1 (fr) * 1994-11-04 1997-01-17 Univ Paris Curie Procede de dissociation des cellules eucaryotes en culture
US5728580A (en) * 1996-02-20 1998-03-17 Cornell Research Foundation, Inc. Methods and culture media for inducing single cell suspension in insect cell lines
DK1975177T3 (da) 1996-03-01 2011-07-25 Novo Nordisk As Appetitundertrykkende peptid, formuleringer dermed og anvendelse deraf
JP2000507812A (ja) * 1996-03-12 2000-06-27 ライフ テクノロジーズ,インコーポレイテッド 造血細胞培養栄養補充成分
EP2243827B2 (de) * 1996-08-30 2017-11-22 Life Technologies Corporation Serumfreies kulturmedium für säugerzellen und seine verwendung
CA2286395C (en) 1997-04-03 2009-06-23 Yoshitomi Pharmaceutical Industries Ltd. Production method of heterologous protein
US5804420A (en) * 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
US6066602A (en) * 1997-08-07 2000-05-23 Becton Dickinson And Company Waterborne non-silicone lubricant comprising phospholipid and polyether
US6051401A (en) * 1998-07-28 2000-04-18 Bayer Corporation Methods and constructs for protein expression
AT409379B (de) * 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
US6670184B2 (en) * 2000-06-23 2003-12-30 Basf Ag Method for producing a lipid emulsion for use in insect cell culture
DE10050091A1 (de) * 2000-10-09 2002-04-25 Biotechnolog Forschung Gmbh Casein-Peptidfragmente mit wachstumsbeeinflußender Aktivität auf Zellkulturen
US7445924B2 (en) * 2000-11-23 2008-11-04 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant and cultivation method
IL157842A0 (en) 2001-03-22 2004-03-28 Novo Nordisk Healthcare Ag Coagulation factor vii derivatives
WO2002090533A2 (en) * 2001-05-07 2002-11-14 National Research Council Of Canada Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells
GB0123098D0 (en) 2001-09-26 2001-11-14 Lonza Biologics Plc Use of aminoglycoside resistance gene
US6943023B2 (en) * 2002-03-06 2005-09-13 National Institute Of Agrobiological Sciences Insect cell primary culture medium, extra cellular matrix, and process of preparing an insect culture cell line in a short period of time using the medium and matrix
AU2003264144C1 (en) 2002-09-05 2009-12-17 Bavarian Nordic A/S Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
EP2392655A3 (de) 2003-09-09 2012-02-29 Novo Nordisk Health Care AG Gerinnungsfaktor VII Polypeptide
US7087369B2 (en) * 2003-12-17 2006-08-08 The Regents Of The University Of California Cornea preservation medium
EP2305821A3 (de) 2004-02-13 2011-04-13 Novozymes A/S Proteasevarianten
US7422875B2 (en) * 2004-07-20 2008-09-09 Board Of Regents Of The University Of Nebraska Compositions and methods for increasing protein production
MX2007012887A (es) 2005-04-18 2007-12-10 Novo Nordisk As Variantes il-21.
WO2007031559A2 (en) 2005-09-14 2007-03-22 Novo Nordisk Health Care Ag Human coagulation factor vii polypeptides
CN105219734B (zh) 2008-12-05 2020-03-03 武田疫苗公司 用于诱导病毒生长的组合物、方法和用途
WO2011006982A2 (en) 2009-07-17 2011-01-20 Rigshospitalet Inhibitors of complement activation
US9815876B2 (en) 2010-03-05 2017-11-14 Omeros Corporation Chimeric inhibitor molecules of complement activation
JP6517018B2 (ja) 2012-02-09 2019-05-22 ヴァー2・ファーマシューティカルズ・アンパルトセルスカブVAR2 Pharmaceuticals ApS コンドロイチン硫酸グリカンのターゲティング
JP2015532307A (ja) 2012-10-15 2015-11-09 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 凝固因子viiポリペプチド
EP2970916B1 (de) 2013-03-13 2021-04-14 Merck Sharp & Dohme Corp. Adaptierte lepidoptera-insektenzellen zur produktion rekombinanter proteine
HUE052232T2 (hu) 2013-05-06 2021-04-28 Scholar Rock Inc Készítmények és eljárások növekedési faktor modulálására
AU2014329403B2 (en) 2013-10-03 2020-10-08 Takeda Vaccines, Inc. Methods of detection and removal of rhabdoviruses from cell lines
CN105441376B (zh) * 2015-12-22 2018-03-20 肇庆大华农生物药品有限公司 一种用于培养病毒的无血清培养基及其制备方法
WO2017195745A1 (ja) * 2016-05-09 2017-11-16 国立研究開発法人医薬基盤・健康・栄養研究所 培地、アルブミン非含有培地用添加剤および多能性幹細胞の培養方法
US20210278406A1 (en) 2018-07-13 2021-09-09 Varct Diagnostic Aps Isolation of circulating cells of fetal origin using recombinant malaria protein var2csa

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US30985A (en) * 1860-12-18 Thomas l
USRE30985E (en) * 1978-01-01 1982-06-29 Serum-free cell culture media
DE3048289A1 (de) * 1980-12-20 1982-07-29 Hoechst Ag "verfahren zur zuechtung von insektenzellen"
JPS5831989A (ja) * 1981-08-13 1983-02-24 Asahi Chem Ind Co Ltd 正常二倍体細胞の培養方法
DE3216163A1 (de) * 1982-04-30 1983-11-03 Behringwerke Ag Kulturmedium und verfahren zur virusvermehrung in suspensionskultur
ATE78293T1 (de) * 1983-05-27 1992-08-15 Texas A & M Univ Sys Verfahren zur herstellung eines rekombinanten baculovirus-expressionsvektors.
DK518384A (da) * 1984-01-31 1985-07-01 Idaho Res Found Vektor til fremstilling af et gen-produkt i insektceller, fremgangsmaade til dens fremstilling samt dens anvendelse
US4485029A (en) * 1984-03-19 1984-11-27 Minnesota Mining And Manufacturing Company Disinfecting method and compositions
US4752585A (en) * 1985-12-17 1988-06-21 Cetus Corporation Oxidation-resistant muteins
JPH0615447B2 (ja) * 1985-12-02 1994-03-02 進 前田 ウイルスを利用した殺虫剤及びその調製法

Also Published As

Publication number Publication date
IE882264L (en) 1989-01-24
JPH03500602A (ja) 1991-02-14
IL87196A (en) 1993-04-04
IL87196A0 (en) 1988-12-30
EP0380495B1 (de) 1994-05-18
CA1309679C (en) 1992-11-03
US5024947A (en) 1991-06-18
WO1989001028A1 (en) 1989-02-09
IE64262B1 (en) 1995-07-26
EP0380495A1 (de) 1990-08-08
DE3889665D1 (de) 1994-06-23
AU2126688A (en) 1989-03-01
DE3889665T2 (de) 1994-11-03
JP2898291B2 (ja) 1999-05-31

Similar Documents

Publication Publication Date Title
DE3889665D1 (de) Serumfreie wachstumsmedien für insektenzellen und expression von produkten damit.
GB2091271B (en) Recombinant dna
DK112686A (da) Fremgangsmaade og apparat til dyrkning af cellekulturer
DE69023873D1 (de) Statischer oxygenator zur suspensionskultur von tierischen zellen.
IL68366A (en) Process for expressing a gene encoding a protein comprising the enzymatic portion of human urokinase in a microorganism or cell culture
KR880007726A (ko) 안정하게 형질감염된 포유동물 세포에서 사람 에리트로포이에틴 유전자를 고농도 형질발현시키는 방법
DE3851035D1 (de) Interleukin-7.
DE69033961D1 (de) Zellinien, die einen biologisch aktiven faktor-ix exprimieren
DE3769872D1 (de) Herstellung von rekombinantem protein.
RU94043769A (ru) Способ повышения продукции протеина с, способ повышения уровня его модификации
IL77049A0 (en) Isolation and culture of adrenal medullary endothelial cells producing blood clotting factor viii:c
CA1312566C (en) Method for increasing the expression of polypeptides in recombinant cell culture
ATE97958T1 (de) Zellenzuchtverfahren fuer die produktion von aktiviertem protein-c.
AU581819B2 (en) Process for the immortalization of human and animal cells
ATE67782T1 (de) Cholesterolreiche fraktion, verfahren dafuer und verwendung derselben zur zellkultur.
ATE288476T1 (de) Herstellung von proteinen
DE69014723D1 (de) Zellzüchtungsverfahren.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee